TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways
Shoutang Wang(University of Hong Kong), Marco Colonna(Washington University in St. Louis), Cecília Pessoa Rodrigues(Howard Hughes Medical Institute), Jinchao Hou(Tianjin University of Science and Technology), Wandy L. Beatty(Washington University in St. Louis), Khai M. Nguyen(Washington University in St. Louis), Vincent Peng(University of California, San Francisco), Carla M. Yuede(Washington University in St. Louis), Susan Gilfillan(Washington University in St. Louis), Ali H. Ellebedy(Washington University in St. Louis), Siling Du(The University of Texas Southwestern Medical Center), Marina Cella(Centre National de la Recherche Scientifique), Tingting Lei(Washington University in St. Louis), Yingyue Zhou(Washington University in St. Louis), Siyan Cao(Unknown), Raki Sudan(Washington University in St. Louis), Pietro Luigi Poliani(University of Brescia), Zhangying Cai(University of Pennsylvania), Kent Lin(Washington University in St. Louis), David M. Holtzman(Hope Center for Neurological Disorders), Gordon D. Brown(University of Cape Town), Yun Chen(Yale University), Simone Brioschi(Washington University in St. Louis)
Cited by 467
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
An atlas of active enhancers across human cell types and tissues
|Nature|2014|2.8k
Alzheimer disease
|Nature Reviews Disease Primers|2021|2.4k